WEDNESDAY, Feb. 19, 2025 (HealthDay News) — Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital organs through inflammation. But a newer lupus drug appears to protect patients from much of this organ damage, a new study suggests. Anifrolumab (brand nameContinue Reading
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced diseaseContinue Reading
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
WEDNESDAY, Jan. 15, 2024 (HealthDay News) — People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the arteries. Lupus patients with skin symptoms are 72% more likely to develop atherosclerotic heart disease, in which arteries become clogged and less flexible, researchers reported inContinue Reading
THURSDAY, Jan. 9, 2025 (HealthDay News) — A pain-relieving medication might be safer for seniors than first thought. A new study published Jan. 7 in the Annals of Internal Medicine says Gabapentin is widely used to help treat chronic pain and nerve pain, particularly as an alternative to opioid painkillers.Continue Reading
THURSDAY, Dec. 19, 2024 (HealthDay News) — Parkinson’s is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the disabling neurological illness. It’s early research, still in the animal-testing stage, as explained byContinue Reading
WEDNESDAY, Nov. 27, 2024 (HealthDay News) — The blood-brain barrier is a natural membrane that protects your brain from toxins and germs. Unfortunately, this barrier also hampers the delivery of important medicines and therapies into the brain. But researchers now think they’ve figured out a way to get drugs pastContinue Reading
FRIDAY, Nov. 15, 2024 (HealthDay News) — Cases of the autoimmune skin condition eczema appear to rise in areas most plagued by air pollution, new research shows. Since data has long shown that rates of eczema — clinically known as atopic dermatitis — increase along with industrialization, dirty air mightContinue Reading
THURSDAY, Oct. 31, 2024 (HealthDay News) — A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds. Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson’s and Alzheimer’sContinue Reading
FRIDAY, Oct. 24, 2024 (HealthDay News) — Certain gut microbes might be linked to a person’s risk of developing Parkinson’s disease, a new study suggests. People prescribed multiple courses of penicillin antibiotics have a modestly lower risk of developing Parkinson’s, researchers found. Those antibiotics might be affecting bacterial populations inContinue Reading